Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines
申请人:——
公开号:US20040023946A1
公开(公告)日:2004-02-05
Novel substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1 ,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines, use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds, and a method of treatment employing these compounds and compositions. The compounds show a high and selective binding affinity to the histamine H3 receptor indicating histamine H3 receptor antagonistic, inverse agonistic or agonistic activity. As a result, the compounds are useful for the treatment of diseases and disorders related to the histamine H3 receptor.
这篇文章介绍了一种新型的代替品,包括取代的六氢吡咯并[1,2-a]吡嗪、八氢吡咯并[1,2-a]吡嗪和十氢吡嗪并[1,2-a]氮杂七环,以及这些化合物的药物组成物的使用,包括这些化合物的药物组成物,以及使用这些化合物和组成物的治疗方法。这些化合物表现出对组胺H3受体的高度和选择性结合亲和力,表明具有组胺H3受体拮抗、反向激动剂或激动剂活性。因此,这些化合物可用于治疗与组胺H3受体相关的疾病和障碍。